MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Evaluation of quality of life (QOL), patient- and clinician-reported outcomes with deutetrabenazine treatment of chorea in Huntington disease in first-HD

    C.M. Testa, D.O. Claassen, D. Oakes, D. Stamler, V. Sung, S. Frank, On behalf of the First-HD HSG Investigators (Richmond, VA, USA)

    Objective: To assess if deutetrabenazine treatment of chorea associated with HD resulted in changes in QoL, Patient Global Impression of Change (PGIC), or Clinical Global…
  • 2016 International Congress

    Cerebellar GABA in essential tremor and dystonic tremor: A MR spectroscopy study

    P. Panyakaew, H.J. Cho, S. Horovitz, M. Hallett (Bethesda, MD, USA)

    Objective: To explore the role of GABA in the pathophysiology of ET and DT by using MR spectroscopy. Background: The mechanisms of tremor in ET…
  • 2016 International Congress

    Exploring the brainstem functions in cervical dystonia

    P. Tocco, M.C. Tozzi, S. Monaco, L. Bertolasi (Verona, Italy)

    Objective: To explore the exteroceptive brainstem reflexes in patients with cervical dystonia. Background: Dysfunction of the inhibitory components along the motor system has been reported…
  • 2016 International Congress

    Relation between the clinical features and the standardized heart to mediastinum ratio in cardiac metaiodobenzylguanidine imaging in patients with Parkinson’s disease: A multicenter cross-sectional study

    T. Osada, Y. Morita, K. Ohta, S. Nogawa, K. Takahashi, K. Yamaguchi, D. Yasutomi, M. Seki, Y. Nihei, S. Iwasawa, N. Suzuki (Tokyo, Japan)

    Objective: To investigate relation between the clinical features and the standardized heart to mediastinum (H/M) ratio by cardiac metaiodobenzylguanidine (MIBG) imaging in patients with Parkinson's…
  • 2016 International Congress

    Motor subtypes in Parkinson’s disease are distinguished by alterations in morphology and white matter integrity

    G. Vervoort, I. Leunissen, M. Firbank, E. Heremans, E. Nackaerts, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)

    Objective: This study aimed to extend current knowledge on symptomatic heterogeneity in Parkinson's disease (PD) by investigating structural alterations underpinning FC. Background: The postural instability…
  • 2016 International Congress

    EARLYSTIM: STN-DBS alleviates behavioural side effects of dopamine replacement therapy when compared to best medical treatment

    E. Lhommée, W. Lars, C. Virginie, K. Witt, F. Maier, L. Tonder, L. Timmermann, T. Hälbig, F. Pineau, F. Durif, T. Witjas, J.L. Houeto, P. Krack (Grenoble, France)

    Objective: To compare effects of STN-DBS and dopamine replacement therapy (DRT) on behaviour in PD in a 2 year follow-up study. Background: A large panel…
  • 2016 International Congress

    Conjugal Parkinson´s disease – Real or chance?

    B. Balint, R. Erro, F. Brugger, A. Batla, E. Antelmi, C. Ganos, K.P. Bhatia (London, United Kingdom)

    Objective: To describe the occurrence of three cases of conjugal Parkinson´s disease (PD) in a data set of 160 PD patients with a follow up…
  • 2016 International Congress

    Neuromelanin in Parkinson’s disease: A 3 T MRI study

    S. Pietracupa, A. Martin-Bastida, N.L. Kaim, S. Schwarz, D. Auer, A. Berardelli, P. Piccini (Rome, Italy)

    Objective: The purpose of this study was to investigate whether the signal intensity of the substantia nigra pars compacta (SNc) and locus coeruleus (LC) on…
  • 2016 International Congress

    Disrupted hubs in functional brain networks in subtype-specific Parkinson’s disease

    L. Ma, H. Chen, T. Feng (Beijing, People's Republic of China)

    Objective: To detect the changing pattern in functional network hubs in subtype-specific Parkinson's disease (PD) using resting-state functional magnetic resosonce imaging (Rs-fMRI). Background: PD is…
  • 2016 International Congress

    Increasing placebo response in Parkinson’s disease through apomorphine pre-conditioning

    E. Frisaldi, E. Carlino, L. Giudetti, A. Pampallona, M. Zibetti, M. Lanotte, L. Lopiano, F. Benedetti (Turin, Italy)

    Objective: To see whether a placebo response requires pharmacological pre-conditioning with apomorphine. Background: Placebos have been found to affect the patient's brain in a number…
  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley